Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Queensland Health
Federal Trade Commission
Baxter
Citi
Deloitte
Cantor Fitzgerald
Covington
Julphar

Generated: May 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077965

« Back to Dashboard

NDA 077965 describes NORTRIPTYLINE HYDROCHLORIDE, which is a drug marketed by Ani Pharms Inc, Aurolife Pharma Llc, Mayne Pharma, Mylan, Taro Pharm, Teva, Pharm Assoc, and Taro, and is included in nine NDAs. It is available from twenty-six suppliers. Additional details are available on the NORTRIPTYLINE HYDROCHLORIDE profile page.

The generic ingredient in NORTRIPTYLINE HYDROCHLORIDE is nortriptyline hydrochloride. There are eleven drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the nortriptyline hydrochloride profile page.
Summary for 077965
Tradename:NORTRIPTYLINE HYDROCHLORIDE
Applicant:Taro
Ingredient:nortriptyline hydrochloride
Patents:0
Therapeutic Class:Antidepressants
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 077965

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;ORALStrengthEQ 10MG BASE/5ML
Approval Date:Jun 20, 2006TE:AARLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
McKesson
Deloitte
Moodys
Johnson and Johnson
Healthtrust
Cipla
UBS
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.